about
Immune Infiltration and Prostate CancerUpdate on the challenges and recent advances in cancer immunotherapyCurrent early diagnostic biomarkers of prostate cancerScreening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells.Effects of oxygen on the antigenic landscape of prostate cancer cells.Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine DesignTrial watch: DNA vaccines for cancer therapy.Emerging roles of human prostatic Acid phosphataseTargeting kallikrein-related peptidases in prostate cancer.Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.Trial Watch: DNA vaccines for cancer therapy.Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells.Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis.Lentivirus-Induced Dendritic Cells (iDC) for Immune-Regenerative Therapies in Cancer and Stem Cell Transplantation.
P2860
Q26798412-3CB55BFB-8E65-4EBD-A8D2-7D158E05D42DQ27014693-3401EBB3-0D25-4739-B0A9-B78B99EF0D61Q33922390-27711191-B14B-40C6-AF12-8EE87E10F7A9Q35543331-E65C6E07-D701-4C80-A867-17BCB637C9A7Q35845496-5A3B5AF5-3F54-4CB7-8B12-2542DAE9CEB3Q36487242-0E78CE20-B515-47EE-A2F0-14BA3BB05BD0Q36845824-76D320B7-36E6-4758-9A5E-8E76BF1AF39BQ37145460-168E53A9-F9E7-4EAE-B5D5-BF758C203E78Q38191293-417D4215-7CA7-45AC-A1AA-41F95F61F309Q38413737-36A96195-B21F-4893-B11C-F9E6DF439F42Q42552005-AEAE53E9-4D85-4B67-A1DB-35A6101D861BQ43725536-65E9CCC8-09DB-484E-A059-AA40D75F2DF8Q51065162-29BE9DC9-BFFB-4235-A34A-31A435315128Q53563179-9D20A708-0788-4BB2-81D9-023849494395Q53809365-A8770376-A3B5-42F8-9001-AAE286F33758Q53891545-9E4DEB72-A0EC-4902-86E3-BDAE8F8C1B34
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The evolving role of immunotherapy in prostate cancer.
@en
type
label
The evolving role of immunotherapy in prostate cancer.
@en
prefLabel
The evolving role of immunotherapy in prostate cancer.
@en
P2860
P356
P1433
P1476
The evolving role of immunotherapy in prostate cancer.
@en
P2093
W R Gerritsen
P2860
P304
P356
10.1093/ANNONC/MDS259
P478
23 Suppl 8
P577
2012-09-01T00:00:00Z